Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $407.5600 (-1.67%) ($404.8370 - $413.7600) on Mon. Mar. 18, 2019. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 2.02% (three month average) | | RSI | 42 | | Latest Price | $407.5600(-1.67%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | REGN declines -0.2% a day on average for past five trading days. | | Weekly Trend | REGN declines -2.5% a week on average for past two weeks. | | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability)
IBB(59%) XLV(48%) IVW(41%) IWF(40%) QQQ(40%) | | Factors Impacting REGN price | REGN will decline at least -1.01% in a week (0% probabilities).
UUP(-11%) VXX(-10%) TLT(-6%) IFRA(-6%) XHB(-4%) | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -1.01% (StdDev 2.02%) | | Hourly BBV | 0 () | | Intraday Trend | -0.6% | | | | | |
|
| Resistance Level | $420.13 | | 5 Day Moving Average | $411.23(-0.89%) | | 10 Day Moving Average | $413.78(-1.5%) | | 20 Day Moving Average | $420.13(-2.99%) | | To recent high | -7.3% | | To recent low | 19.6% | | Market Cap | $43.213b | | | | | | |
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |